(Q44107506)

English

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation

scientific article published on September 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sirolimus, tacrolimus, and low-dose methotrexate for graft-versus-host disease prophylaxis in mismatched related donor or unrelated donor transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

1

object named as

Joseph H Antin

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Stephanie J. Lee

5

object named as

Stephanie J Lee

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Corey Cutler

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Haesook T. Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730113

30 December 2023

Vincent T. Ho

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730113

30 December 2023

David B. Miklos

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730113

30 December 2023

Ephraim P. Hochberg

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730113

30 December 2023

Catherine J. Wu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730113

30 December 2023

Edwin P. Alyea

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730113

30 December 2023

Robert J. Soiffer

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730113

30 December 2023

language of work or name

0 references

publication date

1 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 September 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12730113

30 December 2023

full work available at URL

https://ashpublications.org/blood/article-pdf/102/5/1601/1690302/h81703001601.pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12730113

30 December 2023

http://ashpublications.org/blood/article-pdf/102/5/1601/1690302/h81703001601.pdf

Portable Document Format

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

102

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1601-1605

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

2

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen

3

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Sirolimus-tacrolimus combination immunosuppression

4

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

CD4+ and CD8+ T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients

6

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease

7

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection

8

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Combined effect of rapamycin and FK 506 in prolongation of small bowel graft survival in the mouse

9

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Synergistic effect of rapamycin and cyclosporine in prevention of acute kidney allograft rejection in the mouse

10

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Effect of tacrolimus (FK506) and sirolimus (rapamycin) mono- and combination therapy in prolongation of renal allograft survival in the monkey

11

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.

13

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

15

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation

19

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age

21

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Effect of HLA matching on outcome of related and unrelated donor transplantation therapy for chronic myelogenous leukemia

22

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program Experience

23

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program

24

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

25

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Combined costimulation blockade plus rapamycin but not cyclosporine produces permanent engraftment

27

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

28

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation

30

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

31

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease

32

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Rapamycin impairs antigen uptake of human dendritic cells

33

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Rapamycin inhibits IL-4--induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo

34

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells, leading to apoptosis via increased p27KIP1 expression

35

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation

36

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

37

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

38

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Efficacy of sirolimus (rapamycin) administered concomitantly with a subtherapeutic dose of cyclosporin in the treatment of severe psoriasis: a randomized controlled trial

39

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation

40

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

De novo hemolytic uremic syndrome after kidney transplantation in patients treated with cyclosporine-sirolimus combination

41

1 reference

10.1182/BLOOD-2003-02-0489

https://api.crossref.org/works/10.1182/BLOOD-2003-02-0489

30 December 2023

Identifiers

10.1182/BLOOD-2003-02-0489

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44107506&oldid=2041741395"